Target
meta-iodobenzguanine
1 abstract
Abstract
Single agent axitinib in the management of patients with progressive pheochromocytoma and paraganglioma.Org: James J. Peters VAMC, Genitourinary Malignancies Branch, NCI, National Institutes of Child Health and Human Development, Clinical Pharmacology Program,